BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 12109133)

  • 1. Progress toward vector design for hematopoietic stem cell gene therapy.
    Hawley RG
    Curr Gene Ther; 2001 May; 1(1):1-17. PubMed ID: 12109133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety concerns related to hematopoietic stem cell gene transfer using retroviral vectors.
    Haviernik P; Bunting KD
    Curr Gene Ther; 2004 Sep; 4(3):263-76. PubMed ID: 15384940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Addition of the human interferon beta scaffold attachment region to retroviral vector backbones increases the level of in vivo transgene expression among progeny of engrafted human hematopoietic stem cells.
    Murray L; Travis M; Luens-Abitorabi K; Olsson K; Plavec I; Forestell S; Hanania EG; Hill B
    Hum Gene Ther; 2000 Sep; 11(14):2039-50. PubMed ID: 11020802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High levels of transgene expression following transduction of long-term NOD/SCID-repopulating human cells with a modified lentiviral vector.
    Gao Z; Golob J; Tanavde VM; Civin CI; Hawley RG; Cheng L
    Stem Cells; 2001; 19(3):247-59. PubMed ID: 11359950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progress toward the genetic treatment of the beta-thalassemias.
    Sadelain M; Lisowski L; Samakoglu S; Rivella S; May C; Riviere I
    Ann N Y Acad Sci; 2005; 1054():78-91. PubMed ID: 16339654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retroviral vector interactions with hematopoietic cells.
    Everson EM; Trobridge GD
    Curr Opin Virol; 2016 Dec; 21():41-46. PubMed ID: 27521874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene transfer into nonhuman primate hematopoietic stem cells: implications for gene therapy.
    Hanazono Y; Terao K; Ozawa K
    Stem Cells; 2001; 19(1):12-23. PubMed ID: 11209087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Development of gene therapy for hematopoietic stem cell using viral vectors].
    Dong WJ; Zu ZX; Liu DP; Liang CC
    Yi Chuan Xue Bao; 2003 Apr; 30(4):382-8. PubMed ID: 12812066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stem Cell Genetic Therapy for Fanconi Anemia - A New Hope.
    Hanenberg H; Roellecke K; Wiek C
    Curr Gene Ther; 2017; 16(5):309-320. PubMed ID: 28067166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of chromatin insulators to improve the expression and safety of integrating gene transfer vectors.
    Emery DW
    Hum Gene Ther; 2011 Jun; 22(6):761-74. PubMed ID: 21247248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3' self-inactivating long terminal repeat inserts for the modulation of transgene expression from lentiviral vectors.
    Manic G; Maurin-Marlin A; Galluzzi L; Subra F; Mouscadet JF; Bury-Moné S
    Hum Gene Ther Methods; 2012 Apr; 23(2):84-97. PubMed ID: 22456436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-level transduction and gene expression in hematopoietic repopulating cells using a human immunodeficiency [correction of imunodeficiency] virus type 1-based lentiviral vector containing an internal spleen focus forming virus promoter.
    Demaison C; Parsley K; Brouns G; Scherr M; Battmer K; Kinnon C; Grez M; Thrasher AJ
    Hum Gene Ther; 2002 May; 13(7):803-13. PubMed ID: 11975847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical gene therapy in hematology: past and future.
    Richter J; Karlsson S
    Int J Hematol; 2001 Feb; 73(2):162-9. PubMed ID: 11372727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An improved vector for high-level, consistent retroviral transgene expression in human thymocytes after competitive reconstitution from transduced peripheral blood stem cells.
    Austin TW; Moss K; Morel F; Plavec I
    Hum Gene Ther; 2001 Jul; 12(10):1239-49. PubMed ID: 11440618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone marrow mesenchymal cells for haemophilia A gene therapy using retroviral vectors with modified long-terminal repeats.
    Van Damme A; Chuah MK; Dell'accio F; De Bari C; Luyten F; Collen D; VandenDriessche T
    Haemophilia; 2003 Jan; 9(1):94-103. PubMed ID: 12558785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene Therapy in Fanconi Anemia: A Matter of Time, Safety and Gene Transfer Tool Efficiency.
    Verhoeyen E; Roman-Rodriguez FJ; Cosset FL; Levy C; Rio P
    Curr Gene Ther; 2017; 16(5):297-308. PubMed ID: 28067165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retroviral vectors for gene therapy of AIDS and cancer.
    Chang LJ; He J
    Curr Opin Mol Ther; 2001 Oct; 3(5):468-75. PubMed ID: 11699891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-transduction events in retrovirus-mediated gene therapy involving hematopoietic stem cells: beyond efficiency issues.
    Medin JA; Fowler DH
    J Cell Biochem Suppl; 2002; 38():46-54. PubMed ID: 12046849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The sheep model of in utero gene therapy.
    Porada CD; Park P; Almeida-Porada G; Zanjani ED
    Fetal Diagn Ther; 2004; 19(1):23-30. PubMed ID: 14646413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simplified retroviral vector gcsap with murine stem cell virus long terminal repeat allows high and continued expression of enhanced green fluorescent protein by human hematopoietic progenitors engrafted in nonobese diabetic/severe combined immunodeficient mice.
    Kaneko S; Onodera M; Fujiki Y; Nagasawa T; Nakauchi H
    Hum Gene Ther; 2001 Jan; 12(1):35-44. PubMed ID: 11177540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.